Gentherm Incorporated designs, develops, manufactures and markets thermal management technologies. The company is headquartered in Northville, Michigan.
| Revenue (TTM) | $1.58B |
| Gross Profit (TTM) | $379.60M |
| EBITDA | $144.75M |
| Operating Margin | 7.10% |
| Return on Equity | 3.74% |
| Return on Assets | 3.89% |
| Revenue/Share (TTM) | $51.73 |
| Book Value | $23.36 |
| Price-to-Book | 1.78 |
| Price-to-Sales (TTM) | 0.82 |
| EV/Revenue | 0.887 |
| EV/EBITDA | 12.26 |
| Quarterly Earnings Growth (YoY) | 798.00% |
| Quarterly Revenue Growth (YoY) | 11.00% |
| Shares Outstanding | $30.67M |
| Float | $30.17M |
| % Insiders | 1.84% |
| % Institutions | 103.63% |
Volatility is currently expanding
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Gentherm (THRM) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Gentherm NASDAQ: THRM raised its full-year 2026 outlook after reporting record quarterly product revenue and stronger-than-expected automotive demand in the second quarter, executives said on the company's earnings call.
Gentherm (THRM) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.54 per share a year ago.
Revenue Growth of 9.5% (ex-FX) Year-over-Year Delivered Record Quarterly Revenue of $416 Million 2026 Full Year Guidance Raised Board Authorized New Stock Repurchase Program of up to $400 Million Strategic Medical Acquisition Broadens Product Portfolio and Expands Channel Access NOVI, Mich., July 23, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced its financial results for the second quarter ended June 30, 2026.
Gentherm acquires Innovative Medical Equipment, adding ThermaZone thermal therapy technology to expand its medical portfolio and growth opportunities.
NOVI, Mich., July 20, 2026 (GLOBE NEWSWIRE) -- Gentherm, a global market leader of innovative thermal management and pneumatic comfort technologies, announced today it received FDA 510(k) clearance for its patented ThermAffyx™ Patient Safety System.
Gentherm (THRM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
NOVI, Mich., July 07, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, will report its financial results for the second quarter 2026 on Thursday, July 23, 2026, and will host a conference call to discuss those results at 8 am (ET) that same day.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on THRM and any ticker you trade — then tracks every position and per-strategy win rate.
